Cargando…

Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden

BACKGROUND: Opioid overdose related injury or death can be prevented by bystander naloxone administration. For naloxone to be present when and where overdoses occur, opioid prevention education and naloxone distribution (OPEND) must be established on a broad level. This is the 30-month follow-up of...

Descripción completa

Detalles Bibliográficos
Autores principales: Troberg, Katja, Isendahl, Pernilla, Blomé, Marianne Alanko, Dahlman, Disa, Håkansson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960176/
https://www.ncbi.nlm.nih.gov/pubmed/35359781
http://dx.doi.org/10.3389/fpubh.2022.811001
_version_ 1784677332628275200
author Troberg, Katja
Isendahl, Pernilla
Blomé, Marianne Alanko
Dahlman, Disa
Håkansson, Anders
author_facet Troberg, Katja
Isendahl, Pernilla
Blomé, Marianne Alanko
Dahlman, Disa
Håkansson, Anders
author_sort Troberg, Katja
collection PubMed
description BACKGROUND: Opioid overdose related injury or death can be prevented by bystander naloxone administration. For naloxone to be present when and where overdoses occur, opioid prevention education and naloxone distribution (OPEND) must be established on a broad level. This is the 30-month follow-up of the first multi-site naloxone project in Sweden, implemented at 31 sites in the County of Skåne 2018. AIM: To address participant characteristics and factors associated with returning for naloxone refill and with having used naloxone for overdose reversal. An additional aim was to describe self-reported reasons for naloxone refill and overdose experiences. METHODS: Data were collected during June 2018—December 2020 through questionnaires at baseline and upon naloxone refill of the initial and subsequent naloxone kit. Descriptive statistics was used to address participant characteristics, those returning for naloxone refill and reporting overdose reversal. Chi-2 test was used for variable comparison between groups. Factors associated with overdose reversals were examined by logistic regression analysis. Reasons for naloxone refill, overdose situation and management were presented descriptively. RESULTS: Among 1,079 study participants, 22% (n = 235) returned for naloxone refill, of which 60% (n = 140) reported a total of 229 overdose reversals. Reversals were more likely to be reported by participants trained at needle exchange programs (NEPs) [adjusted odds ratio (AOR) = 5.18, 95% Confidence interval (CI) = 3.38–7.95)], with previous experience of own (AOR = 1.63, 95% CI = 1.03–2.58) or witnessed (AOR = 2.12, 95% CI = 1.05–4.29) overdose, or who had used sedatives during the last 30 days before initial training (AOR = 1.56, 95% CI = 1.04–2.33). A majority of overdoses reportedly occurred in private settings (62%), where the victim was a friend (35%) or acquaintance (31%) of the rescuer. CONCLUSION: Participants with own risk factors associated with overdose (e.g., injection use, concomitant use of benzodiazepines and previous experience of own overdose) were more likely to report administering naloxone for overdose reversal. Overdose management knowledge was high. The findings indicate that implementation of multi-site OPEND reaches individuals at particularly high risk of own overdose in settings with limited previous harm reduction strategies and favors a further scaling up of naloxone programs in similar settings.
format Online
Article
Text
id pubmed-8960176
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89601762022-03-30 Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden Troberg, Katja Isendahl, Pernilla Blomé, Marianne Alanko Dahlman, Disa Håkansson, Anders Front Public Health Public Health BACKGROUND: Opioid overdose related injury or death can be prevented by bystander naloxone administration. For naloxone to be present when and where overdoses occur, opioid prevention education and naloxone distribution (OPEND) must be established on a broad level. This is the 30-month follow-up of the first multi-site naloxone project in Sweden, implemented at 31 sites in the County of Skåne 2018. AIM: To address participant characteristics and factors associated with returning for naloxone refill and with having used naloxone for overdose reversal. An additional aim was to describe self-reported reasons for naloxone refill and overdose experiences. METHODS: Data were collected during June 2018—December 2020 through questionnaires at baseline and upon naloxone refill of the initial and subsequent naloxone kit. Descriptive statistics was used to address participant characteristics, those returning for naloxone refill and reporting overdose reversal. Chi-2 test was used for variable comparison between groups. Factors associated with overdose reversals were examined by logistic regression analysis. Reasons for naloxone refill, overdose situation and management were presented descriptively. RESULTS: Among 1,079 study participants, 22% (n = 235) returned for naloxone refill, of which 60% (n = 140) reported a total of 229 overdose reversals. Reversals were more likely to be reported by participants trained at needle exchange programs (NEPs) [adjusted odds ratio (AOR) = 5.18, 95% Confidence interval (CI) = 3.38–7.95)], with previous experience of own (AOR = 1.63, 95% CI = 1.03–2.58) or witnessed (AOR = 2.12, 95% CI = 1.05–4.29) overdose, or who had used sedatives during the last 30 days before initial training (AOR = 1.56, 95% CI = 1.04–2.33). A majority of overdoses reportedly occurred in private settings (62%), where the victim was a friend (35%) or acquaintance (31%) of the rescuer. CONCLUSION: Participants with own risk factors associated with overdose (e.g., injection use, concomitant use of benzodiazepines and previous experience of own overdose) were more likely to report administering naloxone for overdose reversal. Overdose management knowledge was high. The findings indicate that implementation of multi-site OPEND reaches individuals at particularly high risk of own overdose in settings with limited previous harm reduction strategies and favors a further scaling up of naloxone programs in similar settings. Frontiers Media S.A. 2022-03-10 /pmc/articles/PMC8960176/ /pubmed/35359781 http://dx.doi.org/10.3389/fpubh.2022.811001 Text en Copyright © 2022 Troberg, Isendahl, Blomé, Dahlman and Håkansson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Troberg, Katja
Isendahl, Pernilla
Blomé, Marianne Alanko
Dahlman, Disa
Håkansson, Anders
Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
title Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
title_full Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
title_fullStr Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
title_full_unstemmed Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
title_short Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
title_sort characteristics of and experience among people who use take-home naloxone in skåne county, sweden
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960176/
https://www.ncbi.nlm.nih.gov/pubmed/35359781
http://dx.doi.org/10.3389/fpubh.2022.811001
work_keys_str_mv AT trobergkatja characteristicsofandexperienceamongpeoplewhousetakehomenaloxoneinskanecountysweden
AT isendahlpernilla characteristicsofandexperienceamongpeoplewhousetakehomenaloxoneinskanecountysweden
AT blomemariannealanko characteristicsofandexperienceamongpeoplewhousetakehomenaloxoneinskanecountysweden
AT dahlmandisa characteristicsofandexperienceamongpeoplewhousetakehomenaloxoneinskanecountysweden
AT hakanssonanders characteristicsofandexperienceamongpeoplewhousetakehomenaloxoneinskanecountysweden